Bio-Rad Laboratories Inc
Closed
SectorHealthcare
281.16 -1.26
Overview
Share price change
24h
Min
279.26
Max
283.95
Income | -731M -11M |
|---|---|
Sales | -101M 592M |
P/E Sector Avg | 48.213 49.712 |
EPS | 1.89 |
Profit margin | -1.858 |
Employees | 7,450 |
EBITDA | -751M -637M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +5.82% upside |
Next Earnings | 30 Jul 2026 |
|---|
Market Cap | -16M 7.7B |
|---|---|
Previous open | 282.42 |
Previous close | 281.16 |
News Sentiment
By Acuity
50%
50%
140 / 342 Healthcare
Bio-Rad Laboratories Inc Chart
Past performance is not a reliable indicator of future results.
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.